These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The Critical Role of Imaging in the Management of Multiple Myeloma. Raza S; Leng S; Lentzsch S Curr Hematol Malig Rep; 2017 Jun; 12(3):168-175. PubMed ID: 28317080 [TBL] [Abstract][Full Text] [Related]
23. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer]. Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100 [TBL] [Abstract][Full Text] [Related]
25. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging. Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579 [TBL] [Abstract][Full Text] [Related]
27. [The role of the magnetic resonance in diagnosis of multiple myeloma]. Dytfeld D; Sosnowski P; Czyz A; Komarnick M Pol Merkur Lekarski; 2007 Aug; 23(134):85-8. PubMed ID: 18044333 [TBL] [Abstract][Full Text] [Related]
28. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death]. Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481 [TBL] [Abstract][Full Text] [Related]
29. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma. Atanackovic D; Luetkens T; Hildebrandt Y; Arfsten J; Bartels K; Horn C; Stahl T; Cao Y; Zander AR; Bokemeyer C; Kröger N Clin Cancer Res; 2009 Feb; 15(4):1343-52. PubMed ID: 19190130 [TBL] [Abstract][Full Text] [Related]
30. [The importance of imaging techniques in the modern treatment of multiple myeloma]. Jurczyszyn A; Małkowski B; Czepiel J; Skotnicki AB Przegl Lek; 2014; 71(4):221-30. PubMed ID: 25141582 [TBL] [Abstract][Full Text] [Related]
39. European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Caers J; Garderet L; Kortüm KM; O'Dwyer ME; van de Donk NWCJ; Binder M; Dold SM; Gay F; Corre J; Beguin Y; Ludwig H; Larocca A; Driessen C; Dimopoulos MA; Boccadoro M; Gramatzki M; Zweegman S; Einsele H; Cavo M; Goldschmidt H; Sonneveld P; Delforge M; Auner HW; Terpos E; Engelhardt M Haematologica; 2018 Nov; 103(11):1772-1784. PubMed ID: 30171031 [TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and prognostic factors in patients with multiple myeloma]. Murakami H; Yokohama A; Saitoh T; Tsukamoto N; Handa H Nihon Rinsho; 2012 Apr; 70 Suppl 2():584-8. PubMed ID: 23134019 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]